However, the VAF of mutant PPM1D in our t-AML/t-MDS cohort is low in the majority of cases, with a median of 0.05 and mean of 0.1, consistent with prior reports (Lindsley et al., 2017). The gene discussed is PPM1D; the disease is myelodysplastic syndrome.